Profound Medical Corp.
PROFNASDAQHealthcare● Active
$6.57
$-0.09(-1.35%)
Market Cap$198804245
P/E Ratio—
52W High$8.95
52W Low$3.76
Profound Medical Corp. (PROF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PROF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $16.38M | $10.17M | $7.20M | $6.68M | $6.87M |
| Cost of Revenue | $4.79M | $3.47M | $2.82M | $3.66M | $3.92M |
| Gross Profit | $11.59M | $6.70M | $4.38M | $3.02M | $2.95M |
| Gross Margin %(computed) | 70.77% | 65.89% | 60.87% | 45.22% | 42.95% |
| Operating Expenses | |||||
| R&D Expenses | $20.96M | $16.15M | $14.38M | $14.69M | $15.28M |
| G&A Expenses | $0.00M | $0.00M | $9.17M | $9.46M | $10.31M |
| Total Operating Expenses | $53.57M | $38.17M | $33.00M | $35.15M | $33.24M |
| Operating Income | ($41.98M) | ($31.47M) | ($28.62M) | ($32.13M) | ($30.29M) |
| Operating Margin %(computed) | -256.27% | -309.57% | -397.50% | -480.86% | -440.72% |
| Interest Income | $1.09M | $1.37M | $1.64M | $1.05M | $0.20M |
| Interest Expense | $0.00M | $0.00M | $0.77M | $0.17M | $0.07M |
| Income Before Tax | ($43.06M) | ($26.48M) | ($28.70M) | ($28.38M) | ($30.59M) |
| Income Tax Expense | $0.26M | ($0.00M) | ($0.13M) | $0.29M | $0.10M |
| Net Income | ($43.32M) | ($26.48M) | ($28.57M) | ($28.67M) | ($30.70M) |
| Net Margin %(computed) | -264.44% | -260.45% | -396.85% | -429.11% | -446.66% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.43 | $-1.07 | $-1.35 | $-1.38 | $-1.50 |
| Wtd Avg Shares | 30.23M | 24.77M | 21.18M | 20.83M | 20.46M |
| EBITDA | ($41.41M) | ($25.59M) | ($26.78M) | ($26.60M) | ($28.65M) |
| EBITDA Margin %(computed) | -252.79% | -251.70% | -372.01% | -398.20% | -416.82% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Profound Medical Corp. data
About Profound Medical Corp. (PROF) Income Statement
Profound Medical Corp. (PROF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, PROF reported revenue of $0.02B, gross profit of $0.01B (gross margin 70.77%), and net income of ($0.04B) — a net profit margin of -264.44%.
Frequently asked questions
PROF · 4 questionsProfound Medical Corp. (PROF) reported revenue of $0.02B for 2025, up 61.1% year-over-year.
PROF revenuePROF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09